RenovoRx (RNXT) News Today → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free RNXT Stock Alerts $1.37 +0.07 (+5.38%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024businesswire.com - May 2 at 9:00 AMRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirementfinance.yahoo.com - April 26 at 2:26 AMRenovoRx meets Nasdaq stockholders equity requirementinvesting.com - April 20 at 12:30 AMRenovoRx répond aux exigences du Nasdaq en matière de capitaux propresfr.investing.com - April 18 at 7:28 PMRenovoRx Regains Compliance with Nasdaq Stockholders' Equity Requirementbusinesswire.com - April 18 at 8:30 AMRenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meetingbusinesswire.com - April 16 at 8:30 AMRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026finance.yahoo.com - April 15 at 8:09 AMRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026businesswire.com - April 15 at 8:00 AMRNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023investorplace.com - April 8 at 2:02 PMRNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023investorplace.com - April 8 at 1:52 PMRenovoRx Announces $11.1 Million at Market Private Placementbusinesswire.com - April 8 at 8:30 AMRenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024businesswire.com - April 5 at 8:30 AMRenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024finance.yahoo.com - March 12 at 10:22 AMRenovoRx announces key leadership promotionsinvesting.com - March 10 at 7:24 PMRenovoRx annonce des promotions à des postes clésfr.investing.com - March 8 at 8:03 PMRenovoRx Highlights Key Leadership Promotionsfinance.yahoo.com - March 8 at 8:03 PMRenovoRx obtient un financement pour un essai de phase III sur le cancerfr.investing.com - February 6 at 4:13 PMRenovoRx closes $6.1M private placementmsn.com - January 29 at 10:35 AMRenovoRx Closes $6.1 Million Private Placementfinance.yahoo.com - January 29 at 10:35 AMRenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancerfinance.yahoo.com - December 21 at 10:23 AMRenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meetingfinance.yahoo.com - December 19 at 10:43 AMRenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platformfinance.yahoo.com - December 13 at 10:16 AMRenovoRx Inc RNXTmorningstar.com - December 9 at 1:51 PMMaxim Group Downgrades RenovoRx (RNXT)msn.com - November 16 at 3:31 PMRenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.finance.yahoo.com - November 16 at 10:30 AMRenovoRx GAAP EPS of -$0.13msn.com - November 14 at 4:30 PMRenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlightsfinance.yahoo.com - November 14 at 8:54 AMRenovoRx, Inc. (RNXT) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - October 9 at 9:54 AMRenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023finance.yahoo.com - October 2 at 12:46 PMRoth MKM Maintains RenovoRx (RNXT) Buy Recommendationmsn.com - August 18 at 11:49 PMRenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlightsfinance.yahoo.com - August 17 at 9:29 AMRenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conferencefinance.yahoo.com - July 31 at 1:00 PMRenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platformfinance.yahoo.com - July 20 at 8:55 AMRenovoRx Inc.barrons.com - July 18 at 2:45 PMAnalysts Offer Insights on Healthcare Companies: Creative Medical Technology Holdings (CELZ), Boston Scientific (BSX) and RenovoRx (RNXT)markets.businessinsider.com - July 17 at 8:51 AMRenovoRx, Inc. Stock Presents A Compelling Value Proposition After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)benzinga.com - July 11 at 9:26 AMRenovoRx, Inc. Stock Surges After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)benzinga.com - July 5 at 9:55 AMWhy RenovoRx Stock Is Moving Todaymsn.com - June 29 at 7:59 PMRenovoRx encountering "a lot of enthusiasm" for innovative cancer platformfinance.yahoo.com - June 29 at 2:59 PMMicrocap Biotech Stock RenovoRx is Shooting Higher Today: Here's Whybenzinga.com - June 29 at 2:59 PMRenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancerfinance.yahoo.com - June 29 at 9:59 AMCatalyst Watch: RenovoRx, Inc. Stock Jumps 14% Ahead of Thursday's Phase III TIGeR-PaC Trial Update ($RNXT)benzinga.com - June 28 at 1:16 PMPre-market Movers: ASTS, AREB, RNXT, COYA, BANL…markets.businessinsider.com - June 28 at 8:16 AMCatalyst Watch: RenovoRx, Inc. Nears June 29th Data Release From Its Phase III TIGeR-PaC Trial Targeting Pancreatic Cancer ($RNXT)benzinga.com - June 26 at 10:19 AMRenovoRx Appoints Margaret A. Tempero, M.D., to Scientific Advisory Boardfinance.yahoo.com - June 20 at 10:20 AMRenovoRx Announces ROTH Capital Key Opinion Leader (KOL) Webcast on June 15finance.yahoo.com - June 12 at 5:10 PMRenovoRx Initiates Patient Enrollment at University of Texas Southwestern Medical Center for Pivotal Phase III TIGeR-PaC Clinical Trialfinance.yahoo.com - June 1 at 9:43 AMRenovoRx, Inc.: RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancerfinanznachrichten.de - May 25 at 12:55 PMRenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancerfinance.yahoo.com - May 25 at 12:55 PMRenovoRx to Present at the LD Micro Invitational XIII Conferencefinance.yahoo.com - May 24 at 9:46 AM Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. RNXT Media Mentions By Week RNXT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNXT News Sentiment▼0.000.36▲Average Medical News Sentiment RNXT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNXT Articles This Week▼01▲RNXT Articles Average Week Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FLGC News TXMD News BNTC News ONTX News SYBX News ONCT News MEIP News TCRT News LSTA News CPIX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNXT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
